INBS — Intelligent Bio Solutions Share News
0.000.00%
Last trade - 00:00- $5.27m
- $1.06m
- $4.22m
Brief: Intelligent Bio Solutions Provides Updated Timeline For Anticipated FDA 510(K) Submission And Clearance
Brief: Intelligent Bio Updates FDA 510(k) Progress for Fingerprint Drug Test System, Highlights Accuracy & Readiness
Brief: Intelligent Bio Reports Strong Q4 Revenue Growth and Operational Momentum
Brief: Intelligent Bio Solutions Strengthens FDA 510(K) Package With New Cybersecurity And Performance Data
Brief: Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
Brief: Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra
Brief: Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge
Brief: Intelligent Bio Solutions Announces Proposed Public Offering Of Common Stock
Brief: Intelligent Bio Solutions Achieves 94.1% Accuracy In Method Comparison Study
Brief: Intelligent Bio Solutions Announces Positive Results Of PK Study, A Key Milestone On Path To FDA 510(K) Submission
Brief: Intelligent Bio Solutions Concludes In-Clinic Testing For Clinical Study Plan
Brief: Intelligent Bio Solutions Inc Entered Into At Market Offering Agreement With Ladenburg Thalmann & Co. Inc
Brief: Intelligent Bio Solutions Reduces Board Size To Four Members
Brief: Intelligent Bio Solutions Inc. Advances On FDA 510(K) Pathway With Biocompatibility Study Success
Brief: Intelligent Bio Solutions Completes In-Clinic Portion Of Pharmacokinetic Study
Brief: Intelligent Bio Begins Subject Dosing And Sampling For Drug Screening Technology Study
Brief: Intelligent Bio Solutions Implements Strategic Reorganization Plan To Support Global Growth Initiatives
Brief: Intelligent Bio Unit Granted New European Patent With Unitary Effect For Fingerprinting DSR-Plus Cartridge Reader